Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
Ahmed TorkyNinet SinaiiSmita JhaJay DesaiDiala El-MaoucheAshwini MallappaDeborah P MerkePublished in: The Journal of clinical endocrinology and metabolism (2021)
Patients with CAH develop metabolic morbidity at a young age associated with treatment-related and familial factors. Judicious use of glucocorticoid and mineralocorticoid is warranted.